Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BlueWillow Biologics

www.bluewillow.com

Latest From BlueWillow Biologics

Venture Funding Deals: Two Companies With China Ties Raise $260m Each

Suzhou-based immuno-oncology specialist CStone raised a $260m Series B round and Brii launched with $260m in Series A cash to develop drugs for the China market. Also, multiple start-ups launched recently with more than $50m in Series A rounds, including Ansun, Beam, Casma, Celsius and Neurana.

Deals Financing

Finance Watch: Lots Of Money, Big And Small, Flowing Into Drug Development

Big venture capital bets continue in biopharma, including Foresite's new $668m fund and Merck's $125m investment in Moderna, but small VC rounds could be making a comeback. In public company financings, Aslan and Evelo launched in the US, while Ascletis is testing Hong Kong’s IPO market.

Financing StartUps and SMEs

BioNotebook: BioMeter reads fewer, higher-value deals; trials progress, partnerships inked

The fourth quarter of 2013 offered a mixed bag for biotechnology licensing deals; there were fewer transactions, but with much higher upfront payments than in previous quarters, according to law firm Morrison & Foerster's BioMeter report.

Dermatology Infectious Diseases

Recent Financings Of Private Companies, December 2012

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings of Start-Ups column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Pharmaceuticals, and Medical Devices sectors.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Topical Delivery
    • Vaccines
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • NanoBio Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BlueWillow Biologics
  • Senior Management
  • David Peralta, CEO
    Tarek Hamouda, MD, PhD, Sr. Dir., Clinical Research
  • Contact Info
  • BlueWillow Biologics
    Phone: (734) 302-4000
    2311 Green Rd.
    Ste. A
    Ann Arbor, MI 48105
    USA
UsernamePublicRestriction

Register